B dot Medical Successfully Develops Compact Bending Magnet for Proton Beam Using Superconducting...

B dot Medical

2021/6/28 16:00

TOKYO, June 28, 2021 /Kyodo JBN/ --

 B dot Medical Inc.

B dot Medical Successfully Develops Compact Bending Magnet for Proton Beam Using Superconducting Technology

 

- To Realize Compact and Low-cost Proton Therapy System -

 

B dot Medical Inc. has confirmed the superconductivity of a superconducting bending magnet designed and manufactured at its factory by cooling and conducting an energization test on a compact proton cancer therapy system under development, and confirmed the generation of a high magnetic field. That means a big step closer to the development concept of the product, which is to make the system significantly smaller and less expensive.

 

Proton therapy can precisely irradiate tumors deep inside the body, thus minimizing damage to surrounding normal tissues and organs. However, the current proton therapy system is very large because it uses a huge normal-conducting electromagnet for the gantry, which generates a strong magnetic field to bend the high-speed proton beam inside the magnet and rotate it around the patient. In addition to that, the high cost of installation has hindered the spread of proton therapy over the years, and only a few patients are currently receiving it.

 

B dot Medical has devised a proprietary “non-rotating gantry” and is developing an ultra-compact proton therapy system that is completely different from the conventional structures. The non-rotating gantry is realized by combining the technology to bend the proton beam, which is accelerated to more than 70% of the speed of light, inside a superconducting magnet with a high magnetic field, and the technology to optimize the magnetic field shape so that the proton beam converges to a single point no matter from which direction it enters the magnet. In this energization test, the superconducting bending magnet used in the device under development was cooled sufficiently, and then the magnet was energized to confirm the generation of a high magnetic field.

 

The proton beam comes from left to right in the figure and is bended in the superconducting magnet: https://kyodonewsprwire.jp/prwfile/release/M105528/202106236636/_prw_PI1fl_IWawqbzF.jpg

 

Appearance of the superconducting magnet:

https://kyodonewsprwire.jp/prwfile/release/M105528/202106236636/_prw_PI2fl_y2x388H2.jpg

 

The next step will be a pattern operation test to quickly control the strong magnetic field generated by the superconducting magnet, and then B dot Medical will proceed to a proton beam test to apply for PMDA (Pharmaceutical and Medical Device Act) approval. With the aim of commercializing the product as soon as possible, B dot Medical will promote the spread of proton therapy with the proton cancer therapy system, which has been significantly downsized using breakthrough technology.

 

About B dot Medical Inc.

B dot Medical Inc. is a start-up that originated at the National Institute of Radiological Sciences (NIRS) and is developing an “ultra-compact proton cancer therapy system” by utilizing the advanced technology and experience cultivated at NIRS. Its developing system is significantly smaller and less expensive than conventional systems and can be installed or replaced in existing X-ray treatment rooms. To promote the spread of proton therapy, B dot Medical is developing the device with national grants (i.e. from the New Energy and Industrial Technology Development Organization (NEDO), the Japan Agency for Medical Research and Development (AMED)).

 

Ultra-compact proton cancer therapy system under development: https://kyodonewsprwire.jp/prwfile/release/M105528/202106236636/_prw_PI3fl_Mpn606cO.jpg

 

Company information

Name: B dot Medical Inc.

Address: 5-10-10 Harue-cho, Edogawa-ku, Tokyo 134-0003 JAPAN

Representative: Takuji Furukawa, President and CEO

Foundation: March 1, 2017

Business activity:

1) Consulting support of particle therapy

2) Proton therapy system (under development)

HP: https://bdotmed.co.jp/en/

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

プレスリリース添付画像

| Small | Normal |
| Original |

| Small | Normal |
| Original |

Ultra-compact proton cancer therapy system under development

| Small | Normal |
| Big | Original |

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

このプレスリリースを配信した企業・団体

  • 名称 株式会社ビードットメディカル
  • 所在地 東京都
  • 業種 その他サービス業
  • URL http://bdotmed.co.jp/
  • ※購読している企業の確認や削除はWebプッシュ通知設定画面で行なってください
  • SNSでも最新のプレスリリース情報をいち早く配信中